ConductScience.org, home

Paper72602

Specificity of antisera produced against bleomycin.

Strong JE and 2 others. Cancer Treat Rep, 1977. Cited by 19 papers, by iCite.

Cite this record

ConductScience Library. Specificity of antisera produced against bleomycin. Papers, record 72602. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/72602

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Specificity of antisera produced against bleomycin.
PubMed
Journal
Cancer Treat Rep
PubMed
Year
1977
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
19
iCite
Relative citation ratio, by iCite
1.33
iCite
Revised in PubMed
2003-11-14
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Strong JEJ E
2Broughton AA
3Crooke STS T

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
BleomycinMajor topic
RadioimmunoassayMajor topic
Animals
Antibody Specificity
Goats
Rabbits

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 19 citations.

PMIDTitleJournalYearIn PapersSource
6994913The practical benefits of pharmacokinetics in the use of antineoplastic agents.Cancer Chemother Pharmacol1980https://conductscience.org/library/papers/6994913PubMed
6183016Bleomycin clinical pharmacology by radioimmunoassay.Cancer Chemother Pharmacol1982https://conductscience.org/library/papers/6183016PubMed
93987Pharmacokinetics of bleomycin in man. III. Bleomycin 57Co Vs bleomycin.Cancer Chemother Pharmacol1979https://conductscience.org/library/papers/93987PubMed
86392Bleomycin pharmacokinetics in man. I. Intravenous administration.Cancer Chemother Pharmacol1978https://conductscience.org/library/papers/86392PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/72602

GET https://conductscience.org/api/papers/v1/72602/authors